about
Attachment site recognition and regulation of directionality by the serine integrasesCrystal structure of the bacteriophage P2 integrase catalytic domainGene therapy for hemophiliaSingle-molecule analysis of ϕC31 integrase-mediated site-specific recombination by tethered particle motionCoiled-coil interactions mediate serine integrase directionalityAttachment site selection and identity in Bxb1 serine integrase-mediated site-specific recombination.Generation of a tumor- and tissue-specific episomal non-viral vector system.Correction of dystrophin expression in cells from Duchenne muscular dystrophy patients through genomic excision of exon 51 by zinc finger nucleases.Programmable Genome Editing Tools and their Regulation for Efficient Genome Engineering.Large serine recombinase domain structure and attachment site binding.Bacteriophage recombination systems and biotechnical applications.The ins and outs of serine integrase site-specific recombination.Minicircle DNA vectors for gene therapy: advances and applications.Genomic integration of the full-length dystrophin coding sequence in Duchenne muscular dystrophy induced pluripotent stem cells.Construction of transformed, cultured silkworm cells and transgenic silkworm using the site-specific integrase system from phage φC31.Genome Editing Techniques and Their Therapeutic Applications.Fast identification of reliable hosts for targeted cell line development from a limited-genome screening using combined φC31 integrase and CRE-Lox technologies.Engineering of a target site-specific recombinase by a combined evolution- and structure-guided approach.Simple derivation of transgene-free iPS cells by a dual recombinase approach.Repurposing site-specific recombinases for synthetic biology.
P2860
Q27678897-AB5E9312-1050-4A81-8409-D960B5215674Q27702266-2002AE8C-809B-408A-98AF-87DD9D120B4EQ28081911-CD0AC283-CBAF-4739-8472-F3BA92F22406Q28817301-A11E9EDB-FC7C-4BC7-81C8-C374752DD142Q33878126-35E4565A-0730-46FE-809A-24445CC8F72CQ34711890-7F485193-AC66-42D2-9E61-7ACF97985011Q34756391-E02D3E83-03AA-4279-B00E-898BF800E528Q35153108-524172DA-137F-4B7B-940E-54F28CDDE602Q37613647-09E5CBB3-8B2B-4AD8-8E97-961BA27FC756Q38131813-C24B9FBB-160C-4D31-AFF4-32D42AD75427Q38179994-41F51308-B0D3-4B8D-97AE-8107A65F7251Q38186501-7B2CDB68-BA1A-424C-A793-9CF29F09DC7EQ38300052-52EF57E5-8AEB-4E84-8F83-41CF943539FFQ38718652-495C3C5C-C6FA-495F-A78D-477B8AE214D5Q38978531-991500DE-1721-446B-9294-D66C4C9AFA9AQ38991325-36DD2005-41E0-46E6-911E-28FCBFABC9E3Q39113686-90289CAD-1464-4272-A14E-2D6F99B83AAFQ41835073-466158D8-8A23-4A42-A5BD-421F5036EB9CQ42228486-17EBE21C-1E4E-4394-8AFE-E96E79FBEEC2Q51344618-DC612284-C530-42C7-9BA4-75C5EED2B97D
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Therapeutic applications of the ΦC31 integrase system.
@en
Therapeutic applications of the ΦC31 integrase system.
@nl
type
label
Therapeutic applications of the ΦC31 integrase system.
@en
Therapeutic applications of the ΦC31 integrase system.
@nl
prefLabel
Therapeutic applications of the ΦC31 integrase system.
@en
Therapeutic applications of the ΦC31 integrase system.
@nl
P1433
P1476
Therapeutic applications of the ΦC31 integrase system.
@en
P2093
Christopher L Chavez
Michele P Calos
P304
P356
10.2174/156652311797415818
P407
P577
2011-10-01T00:00:00Z